Clinicopathological features of neuropathy associated with lymphoma

Brain

Volumn 136, Issue 8, 2013, Pages 2563-2578

  Tomita, Minoru ^a   Koike, Haruki ^a   Kawagashira, Yuichi ^a   Iijima, Masahiro ^a   Adachi, Hiroaki ^a   Taguchi, Jun ^b   Abe, Takenori ^c   Sako, Kazuya ^c   Tsuji, Yukiko ^d   Nakagawa, Masanori ^d   Kanda, Fumio ^e   Takeda, Fusako ^f   Sugawara, Masashiro ^f   Toyoshima, Itaru ^f   Asano, Naoko ^g   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIZUOKA RED CROSS HOSPITAL   (Japan)

^c Nakamura Memorial Hospital   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e KOBE UNIVERSITY HOSPITAL   (Japan)

^f AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Demyelination; Lymphoma; Neurolymphomatosis; Neuropathy

Indexed keywords

FLUORODEOXYGLUCOSE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; SOLUBLE INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; B CELL LYMPHOMA; BRAIN ELECTROPHYSIOLOGY; BURKITT LYMPHOMA; CELL INVASION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DEMYELINATING NEUROPATHY; DEMYELINATION; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA CELL; MACROPHAGE; MALE; MANTLE CELL LYMPHOMA; MONONEUROPATHY; NERVE FIBER DEGENERATION; NEUROIMAGING; NEUROPATHY; NONHODGKIN LYMPHOMA; PARANEOPLASTIC NEUROPATHY; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PERIPHERAL T CELL LYMPHOMA; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSORY GANGLIONOPATHY; T CELL LEUKEMIA; T CELL LYMPHOMA; VASCULITIC NEUROPATHY; WALDENSTROEM MACROGLOBULINEMIA;

EID: 84880938350     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt193     Document Type: Article

References (57)

1. Antoine JC, Camdessanché JP. Peripheral nervous system involvement in patients with cancer. Lancet Neurol 2007; 6: 75-86.
2. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27 (Suppl): S21-4.
3. Asano N, Oshiro A, Matsuo K, Kagami Y, Ishida F, Suzuki R, et al. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study. J Clin Oncol 2006; 24: 4626-33.
4. Asano N, Suzuki R, Kagami Y, Ishida F, Kitamura K, Fukutani H, et al. Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am J Surg Pathol 2005; 29: 1284-93.
5. Asano N, Yamamoto K, Tamaru J, Oyama T, Ishida F, Ohshima K, et al. Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 2009; 113: 2629-36.
6. Baehring JM, Batchelor TT. Diagnosis and management of neurolymphomatosis. Cancer J 2012; 18: 463-8.
7. Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH. Neurolymphomatosis. Neuro Oncol 2003; 5: 104-15.
8. Bosch EP, Habermann TM, Tefferi A. Peripheral neuropathy associated with lymphoma, leukemia, and myeloproliferative disorders. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. 4th edn. Philadelphia: Elsevier Saunders; 2005. p. 2489-503.
9. Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology 2011; 76: 705-10.
10. Camdessanché JP, Antoine JC, Honnorat J, Vial C, Petiot P, Convers P, et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain 2002; 125: 166-75.
11. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011; 117: 5019-32.
12. Cheson BD. Role of functional imaging in the management of lymphoma. J Clin Oncol 2011; 29: 1844-54.
13. Correale J, Monteverde DA, Bueri JA, Reich EG. Peripheral nervous system and spinal cord involvement in lymphoma. Acta Neurol Scand 1991; 83: 45-51.
14. Dyck PJ, Dyck PJB, Engelstad J. Pathologic alterations of nerves. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. 4th edn. Philadelphia: Elsevier Saunders; 2005. p. 733-829.
15. Dyck PJ, Lais AC, Karnes JL, Sparks M, Hunder H, Low PA, et al. Permanent axotomy, a model of axonal atrophy and secondary segmental demyelination and remyelination. Ann Neurol 1981; 9: 575-83.
16. Feugier P, van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Fermé C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2005; 23: 4117-26.
17. Giglio P, Gilbert MR. Neurologic complications of non-Hodgkin's lymphoma. Curr Hematol Malig Rep 2006; 1: 214-9.
18. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75: 1135-40.
19. Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 2010; 115: 5005-11.
20. Guberman A, Rosenbaum H, Braciale T, Schlaepfer WW. Human neurolymphomatosis. J Neurol Sci 1978; 36: 1-12.
21. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
22. Hollender A, Kvaloy S, Lote K, Nome O, Holte H. Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis. Eur J Cancer 2000; 36: 1762-8.
23. Hughes RA, Britton T, Richards M. Effects of lymphoma on the peripheral nervous system. J R Soc Med 1994; 87: 526-30.
24. Joint Task Force of the EFNS and the PNS European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. J Peripher Nerv Syst 2010; 15: 1-9.
25. Kelly JJ, Karcher DS. Lymphoma and peripheral neuropathy: a clinical review. Muscle Nerve 2005; 31: 301-13.
26. Kobayashi M, Kato K, Funakoshi K, Watanabe S, Toyoshima I. Neuropathology of paraneoplastic neuropathy with anti-disialosyl antibody. Muscle Nerve 2005; 32: 216-22.
27. Kohut H. Unusual involvement of the nervous system in generalized lymphoblastoma. J Nerv Ment Dis 1946; 103: 9-20.
28. Koike H, Tanaka F, Sobue G. Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. Curr Opin Neurol 2011a; 24: 504-10.
29. Koike H, Atsuta N, Adachi H, Iijima M, Katsuno M, Yasuda T, et al. Clinicopathological features of acute autonomic and sensory neuropathy. Brain 2010; 133: 2881-96.
30. Koike H, Hirayama M, Yamamoto M, Ito H, Hattori N, Umehara F, et al. Age associated axonal features in HNPP with 17p11.2 deletion in Japan. J Neurol Neurosurg Psychiatry 2005; 76: 1109-14.
31. Koike H, Iijima M, Mori K, Yamamoto M, Hattori N, Katsuno M, et al. Nonmyelinating Schwann cell involvement with well-preserved unmyelinated axons in CMT1A. J Neuropathol Exp Neurol 2007; 66: 1027-36.
32. Koike H, Iijima M, Mori K, Yamamoto M, Hattori N, Watanabe H, et al. Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome. J Neurol Neurosurg Psychiatry 2008b; 79: 1171-9.
33. Koike H, Iijima M, Sugiura M, Mori K, Hattori N, Ito H, et al. Alcoholic neuropathy is clinicopahthologically distinct form thiamine-deficiency neuropathy. Ann Neurol 2003; 54: 19-29.
34. Koike H, Kawagashira Y, Iijima M, Yamamoto M, Hattori N, Tanaka F, et al. Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci. J Neurol 2008a; 255: 1526-33.
35. Koike H, Kiuchi T, Iijima M, Ueda M, Ando Y, Morozumi S, et al. Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation. J Neurol Neurosurg Psychiatry 2011b; 82: 1287-90.
36. Koike H, Misu K, Sugiura M, Iijima M, Mori K, Yamamoto M, et al. Pathologic difference of early-vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 2004; 63: 129-38.
37. Koike H, Mori K, Misu K, Hattori N, Ito H, Hirayama M, et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 2001; 56: 1727-32.
38. Kridel R, Dietrich PY. Prevention of CNS relapse in diffuse large B-cell lymphoma. Lancet Oncol 2011; 12: 1258-66.
39. MacKintosh FR, Colby TV, Podolsky WJ, Burke JS, Hoppe RT, Rosenfelt FP, et al. Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer 1982; 49: 586-95.
40. Moore RY, Oda Y. Malignant lymphoma with diffuse involvement of the peripheral nervous system. Neurology 1962; 12: 186-92.
41. Nasu S, Misawa S, Sekiguchi Y, Shibuya K, Kanai K, Fujimaki Y, et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2012; 83: 476-9.
42. Oki Y, Koike H, Iijima M, Mori K, Hattori N, Katsuno M, et al. Ataxic vs painful form of paraneoplastic neuropathy. Neurology 2007; 69: 564-72.
43. Prineas JW, McLeod JG. Chronic relapsing polyneuropathy. J Neurol Sci 1976; 27: 427-58.
44. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 1990; 113: 619-27.
45. Salm LP, van der Hiel B, Stokkel MP. Increasing importance of 18F-fluorodeoxyglucose PET in the diagnosis of neurolymphomatosis. Nucl Med Commun 2012; 33: 907-16.
46. Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A. X-linked recessive bulbospinal neuronopathy, a clinicopathological study. Brain 1989; 112: 209-32.
47. Sobue G, Hashizume Y, Yasuda T, Mukai E, Kumagai T, Mitsuma T, et al. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol 1990b; 79: 402-8.
48. Sobue G, Nakao N, Murakami K, Yasuda T, Sahashi K, Mitsuma T, et al. Type I familial amyloid polyneuropathy. a pathological study of the peripheral nervous system. Brain 1990a; 113: 903-19.
49. Suzuki K, Katsuno M, Banno H, Takeuchi Y, Atsuta N, Ito M, et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain 2008; 131: 229-39.
50. The Non-Hodgkin's Lymphoma Classification Project A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909-18.
51. Vallat JM, de Mascarel HA, Bordessoule D, Jauberteau MO, Tabaraud F, Gelot A, et al. Non-Hodgkin malignant lymphomas and peripheral neuropathies-13 cases. Brain 1995; 118: 1233-45.
52. van den Bent MJ, de Bruin HG, Bos GM, Brutel de la Rivière G, Sillevis Smitt PA. Negative sural nerve biopsy in neurolymphomatosis. J Neurol 1999; 246: 1159-63.
53. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-7.
54. Viala K, Béhin A, Maisonobe T, Léger JM, Stojkovic T, Davi F, et al. Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis? J Neurol Neurosurg Psychiatry 2008; 79: 778-82.
55. Vital C, Vital A, Julien J, Rivel J, deMascarel A, Vergier B, et al. Peripheral neuropathies and lymphoma without monoclonal gammopathy: a new classification. J Neurol 1990; 237: 177-85.
56. Walsh JC. Neuropathy associated with lymphoma. J Neurol Neurosurg Psychiatry 1971; 34: 42-50.
57. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst 2008; 13: 27-46.